Fortress Biotech (FBIO) Total Current Liabilities (2010 - 2026)

Fortress Biotech's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $49.7 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 30.33% year-over-year to $49.7 million; the TTM figure through Dec 2025 stood at $49.7 million (down 30.33% YoY), while the FY2025 annual figure was $49.7 million, down 30.33% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $49.7 million, down from $54.1 million in the prior quarter.
• The five-year high for Total Current Liabilities was $129.5 million in Q1 2023, with the low at $49.7 million in Q4 2025.
• The 5-year median for Total Current Liabilities is $86.3 million (2023), against an average of $87.6 million.
• The sharpest annual moves came in 2021 and 2024: Total Current Liabilities soared 176.85% in 2021, then sank 41.25% in 2024.
• Fortress Biotech's Total Current Liabilities stood at $101.0 million in 2021, then rose by 26.4% to $127.7 million in 2022, then slumped by 33.52% to $84.9 million in 2023, then slipped by 15.91% to $71.4 million in 2024, then slumped by 30.33% to $49.7 million in 2025.
• Business Quant data shows FBIO's Total Current Liabilities at $49.7 million in Q4 2025, $54.1 million in Q3 2025, and $57.5 million in Q2 2025.